Need Assistance?
  • US & Canada:
    +
  • UK: +

Macropin 2

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Macropin 2 has antimicrobial activity. The source of Macropin 2 is venom, the solitary bee Macropis fulvipes.

Category
Functional Peptides
Catalog number
BAT-011980
Molecular Formula
C83H151N27O21S4
Molecular Weight
1991.51
IUPAC Name
(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[2-[[(2S,3R)-2-[(2-aminoacetyl)amino]-3-hydroxybutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
Synonyms
MAC-2
Purity
>95% by HPLC
Sequence
GTGLPMSERRKIMLMMR
InChI
InChI=1S/C83H151N27O21S4/c1-12-47(6)65(79(130)105-57(29-38-135-11)72(123)106-58(39-45(2)3)75(126)103-55(27-36-133-9)71(122)102-54(26-35-132-8)67(118)96-49(43-111)19-15-31-92-81(86)87)109-74(125)50(20-13-14-30-84)98-68(119)51(21-16-32-93-82(88)89)99-69(120)52(22-17-33-94-83(90)91)100-70(121)53(24-25-64(116)117)101-76(127)60(44-112)107-73(124)56(28-37-134-10)104-77(128)61-23-18-34-110(61)80(131)59(40-46(4)5)97-63(115)42-95-78(129)66(48(7)113)108-62(114)41-85/h43,45-61,65-66,112-113H,12-42,44,84-85H2,1-11H3,(H,95,129)(H,96,118)(H,97,115)(H,98,119)(H,99,120)(H,100,121)(H,101,127)(H,102,122)(H,103,126)(H,104,128)(H,105,130)(H,106,123)(H,107,124)(H,108,114)(H,109,125)(H,116,117)(H4,86,87,92)(H4,88,89,93)(H4,90,91,94)/t47-,48+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,65-,66-/m0/s1
InChI Key
LRJHKPIHRBSWBA-ATPLMMOKSA-N
Canonical SMILES
CCC(C)C(C(=O)NC(CCSC)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CCSC)C(=O)NC(CCCN=C(N)N)C=O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CCSC)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)CNC(=O)C(C(C)O)NC(=O)CN
1. Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells
Jiřina Slaninová, Veronika Mlsová, Hilda Kroupová, Lukáš Alán, Tereza Tůmová, Lenka Monincová, Lenka Borovičková, Vladimír Fučík, Václav Ceřovský Peptides. 2012 Jan;33(1):18-26. doi: 10.1016/j.peptides.2011.11.002. Epub 2011 Nov 7.
Recently, we have isolated and characterized remarkable antimicrobial peptides (AMPs) from the venom reservoirs of wild bees. These peptides (melectin, lasioglossins, halictines and macropin) and their analogs display high antimicrobial activity against Gram-positive and -negative bacteria, antifungal activity and low or moderate hemolytic activity. Here we describe cytotoxicity of the above-mentioned AMPs and some of their analogs toward two normal cell lines (human umbilical vein endothelial cells, HUVEC, and rat intestinal epithelial cells, IEC) and three cancer cell lines (HeLa S3, CRC SW 480 and CCRF-CEM T). HeLa S3 cells were the most sensitive ones (concentration causing 50% cell death in the case of the most toxic analogs was 2.5-10 μM) followed by CEM cells. For the other cell lines to be killed, the concentrations had to be four to twenty times higher. These results bring promising outlooks of finding medically applicable drugs on the basis of AMPs. Experiments using fluorescently labeled lasioglossin III (Fl-VNWKKILGKIIKVVK-NH(2)) as a tracer confirmed that the peptides entered the mammalian cells in higher quantities only after they reached the toxic concentration. After entering the cells, their concentration was the highest in the vicinity of the nucleus, in the nucleolus and in granules which were situated at very similar places as mitochondria. Experiments performed using cells with tetramethylrhodamine labeled mitochondria showed that mitochondria were fragmented and lost their membrane potential in parallel with the entrance of the peptides into the cell and the disturbance of the cell membrane.
2. Structure-activity study of macropin, a novel antimicrobial peptide from the venom of solitary bee Macropis fulvipes (Hymenoptera: Melittidae)
Lenka Monincová, Václav Veverka, Jiřina Slaninová, Miloš Buděšínský, Vladimír Fučík, Lucie Bednárová, Jakub Straka, Václav Ceřovský J Pept Sci. 2014 Jun;20(6):375-84. doi: 10.1002/psc.2625. Epub 2014 Mar 11.
A novel antimicrobial peptide, designated macropin (MAC-1) with sequence Gly-Phe-Gly-Met-Ala-Leu-Lys-Leu-Leu-Lys-Lys-Val-Leu-NH2 , was isolated from the venom of the solitary bee Macropis fulvipes. MAC-1 exhibited antimicrobial activity against both Gram-positive and Gram-negative bacteria, antifungal activity, and moderate hemolytic activity against human red blood cells. A series of macropin analogs were prepared to further evaluate the effect of structural alterations on antimicrobial and hemolytic activities and stability in human serum. The antimicrobial activities of several analogs against pathogenic Pseudomonas aeruginosa were significantly increased while their toxicity against human red blood cells was decreased. The activity enhancement is related to the introduction of either l- or d-lysine in selected positions. Furthermore, all-d analog and analogs with d-amino acid residues introduced at the N-terminal part of the peptide chain exhibited better serum stability than did natural macropin. Data obtained by CD spectroscopy suggest a propensity of the peptide to adopt an amphipathic α-helical secondary structure in the presence of trifluoroethanol or membrane-mimicking sodium dodecyl sulfate. In addition, the study elucidates the structure-activity relationship for the effect of d-amino acid substitutions in MAC-1 using NMR spectroscopy.
3. Membrane Association Modes of Natural Anticancer Peptides: Mechanistic Details on Helicity, Orientation, and Surface Coverage
Mayra Quemé-Peña, Tünde Juhász, Gergely Kohut, Maria Ricci, Priyanka Singh, Imola Cs Szigyártó, Zita I Papp, Lívia Fülöp, Tamás Beke-Somfai Int J Mol Sci. 2021 Aug 10;22(16):8613. doi: 10.3390/ijms22168613.
Anticancer peptides (ACPs) could potentially offer many advantages over other cancer therapies. ACPs often target cell membranes, where their surface mechanism is coupled to a conformational change into helical structures. However, details on their binding are still unclear, which would be crucial to reach progress in connecting structural aspects to ACP action and to therapeutic developments. Here we investigated natural helical ACPs, Lasioglossin LL-III, Macropin 1, Temporin-La, FK-16, and LL-37, on model liposomes, and also on extracellular vesicles (EVs), with an outer leaflet composition similar to cancer cells. The combined simulations and experiments identified three distinct binding modes to the membranes. Firstly, a highly helical structure, lying mainly on the membrane surface; secondly, a similar, yet only partially helical structure with disordered regions; and thirdly, a helical monomeric form with a non-inserted perpendicular orientation relative to the membrane surface. The latter allows large swings of the helix while the N-terminal is anchored to the headgroup region. These results indicate that subtle differences in sequence and charge can result in altered binding modes. The first two modes could be part of the well-known carpet model mechanism, whereas the newly identified third mode could be an intermediate state, existing prior to membrane insertion.
Online Inquiry
Verification code
Inquiry Basket